Evidence map›Paper›PMID 41141431›Full record

ReviewThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2025

High Prevalence of

Habtamu Gebrie, Aberham Abere, Anteneh Gashaw, Behailu Taye Gebremeskele, Yeaynmarnesh Asmare Bukayaw, Alem Bayable, Biazin Yenealem Mekuriaw, Eyob Getaneh Yimer, Abel Desalegn Demeke

Abstract readReview
In one paragraph

Review in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Habtamu GebrieDepartment of Medical Laboratory Science, College of Medicine and Health Sciences, Dilla University, P.O. Box 419, Dilla, Ethiopia.ORCID https://orcid.org/0009-0005-0805-8658
Aberham AbereDepartment of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, P.O. Box 196, Gondar, Ethiopia.ORCID https://orcid.org/0000-0003-1886-2373
Anteneh GashawDepartment of Midwifery, College of Medicine and Health Sciences, Dilla University, P.O. Box 419, Dilla, Ethiopia.ORCID https://orcid.org/0009-0002-8396-2186
Behailu Taye GebremeskeleDepartment of Medical Laboratory Science, College of Medicine and Health Sciences, Dilla University, P.O. Box 419, Dilla, Ethiopia.
Yeaynmarnesh Asmare BukayawDepartment of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Science, University of Gondar, P.O. Box 196, Gondar, Ethiopia.
Alem BayableDepartment of Nursing, College of Medicine and Health Science, Dilla University, P.O. Box 419, Dilla, Ethiopia.
Biazin Yenealem MekuriawDepartment of Psychiatry, College of Health and Medical Science, Dilla University, P.O. Box 419, Dilla, Ethiopia.
Eyob Getaneh YimerSchool of Medicine, College of Medicine and Health Sciences, Gondar University, P.O. Box 196, Gondar, Ethiopia.
Abel Desalegn DemekeDepartment of Nursing, College of Medicine and Health Science, Dilla University, P.O. Box 419, Dilla, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Primary research articles on PfHRP2/3 gene deletions (2000-2025) were retrieved from PubMed, Science Direct, and Google Scholar. Eligible studies were systematically searched between May 3 2025, and June 2, 2025. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. Data analysis was performed using STATA Version 17, employing a random effects model. Heterogeneity among studies was evaluated using the Results: A total of 932 studies were initially identified, among these 18 studies were selected for full-text review. After excluding 7 studies, 11 articles were included in the meta-analysis. The overall pooled prevalence of PfHRP2/3 gene deletions was 35.64% (95% CI: 21.43, 49.85). Specifically, the pooled prevalence of PfHRP2 and PfHRP3 gene deletions was 8.48% (95% CI: 0.96, 16.01) and 23.74% (95% CI: 12.16, 35.32), respectively, while concurrent deletions of both genes account for 8.14% (95% CI: 0.67, 15.61). Conclusion: This systematic review and meta-analysis revealed a high prevalence of

Indexed as

Ethiopiagene deletionshistidine-rich proteinPlasmodium falciparum

Identifiers

PMID41141431
PMCPMC12552085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.